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TO THE EDITOR
Patients with the blistering disease epi-
dermolysis bullosa (EB) develop wounds
that are highly susceptible to bacterial
colonization. Recently, we reported that
over 75% of the EB patients sampled
at one particular point of time were
colonized with Staphylococcus aureus
(van der Kooi-Pol et al., 2012). To
determine possible changes in S. aureus
colonization over time, swabs were
collected from the nares, throats, and
wounds of 61 EB patients at three time
points during a period of B2 years. All
S. aureus isolates were typed by
multiple-locus variable number of
tandem repeats analysis (MLVA) and
spa typing. This revealed major
fluctuations in the S. aureus types
sampled from individual EB patients. In
addition, blood samples were obtained
from 13 EB patients to determine their
IgG levels against 43 virulence factors
or whole cells of S. aureus. Overall, the
sera of EB patients contained higher
anti-staphylococcal IgG levels than
those of healthy individuals. Specifi-
cally, this applied to IgGs against
nine important virulence factors,
including the superantigens (SAgs)
staphylococcal enterotoxin M (SEM),
SEN, and SEO. Notably, EB patients
carrying different S. aureus types
contained higher levels of anti-
staphylococcal antibodies than EB
patients colonized by only one type.
Abbreviations: EB, epidermolysis bullosa; ET, exfoliative toxin; HlgB, gamma-hemolysin B; IsaA,
immunodominant antigen A; Isd, iron-responsive surface determinant; Luk, leukocidin; LytM,
peptidoglycan hydrolase; MFI, median fluorescence intensity; MLVA, multiple-locus variable number of
tandem repeats analysis; Nuc, endonuclease; SAgs, superantigens; SasG, S. aureus surface protein G; SCIN,
staphylococcal complement inhibitor; SE, staphylococcal enterotoxin
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Our findings suggest that the immune
system of EB patients is heavily
challenged with S. aureus antigens.
EB is a genetic blistering disease that
renders patients susceptible to coloniza-
tion by the opportunistic pathogen
Staphylococcus aureus (Brandling-
Bennett and Morel, 2010; Graber et al.,
2011; Pope et al., 2012). Recently, we
observed that all EB patients with
chronic wounds, and 75% of patients
without chronic wounds, were colonized
with S. aureus (van der Kooi-Pol et al.,
2012). In contrast, only B30% of the
healthy human population carries this
pathogen (Wertheim et al., 2005).
Persistent S. aureus carriers have an
increased risk for staphylococcal infec-
tions but, compared with noncarriers,
their risk of death due to bacteremia is
lower (Wertheim et al., 2004). This may
relate to increased levels of protective
anti-staphylococcal antibodies upon
long-term exposure to colonizing strains
(Kolata et al., 2011). Furthermore, anti-
staphylococcal antibody levels were
shown to increase strongly during
bacteremia (Verkaik et al., 2010;
Kolata et al., 2011). As high exposure
to S. aureus is a potential health risk for
EB patients, our present studies were
first aimed at defining their S. aureus
population over time and, second, at
determining their anti-staphylococcal
IgG levels.
On the basis of informed consent, 61
EB patients from the Dutch Epidermoly-
sis Bullosa Registry were included in our
studies (Supplementary Methods online).
S. aureus colonization was determined
in three rounds of sampling at half-
yearly intervals. In each round, swabs
were collected from three wounds, the
left and right anterior nares, and the
throat. A total of 43 EB patients partici-
pated in the second sampling round, 40
in the third, and 35 patients participated
in all three sampling rounds. Overall,
we identified 101 different S. aureus
types by molecular typing with MLVA
(Supplementary Methods online and
Supplementary Table S1 online). Only
18 of these MLVA types were encoun-
tered in all rounds (Figure 1a). One
hundred and eighteen strains were also
spa typed, revealing 48 different spa
types (Supplementary Table S1 online).
Next, we compared the variations in
S. aureus types isolated from individual
EB patients over time. This revealed that
the same MLVA type was identified on
B42.5% of all sampled patients with
minor variations for different sites of
sampling (Figure 1b). Furthermore,
58.3% of the patients with chronic
wounds and 43.5% of the patients with-
out chronic wounds carried alternating
S. aureus MLVA types over time. In
8.7% of the patients without chronic
wounds, a different MLVA type was
encountered in each sampling round.
These findings show that the included
EB patients are continuously challenged
by different S. aureus types and that the
carried S. aureus population can change
rapidly. This seems to challenge the
classical dogma that persistent carriers
are mainly colonized by one S. aureus
type (Wertheim et al., 2005). However,
our studies specifically address a patient
group that is highly susceptible to S.
aureus owing to continuous skin defects,
which is different from the situation in
healthy individuals.
To assess the anti-staphylococcal IgG
levels in EB patients, we first performed
whole-cell ELISAs using an S. aureus
mutant lacking the IgG-binding proteins
Spa and Sbi, and IgGs isolated from
patients with chronic wounds. Sera from
healthy donors were used as controls.
This revealed that EB patient sera con-
tained significantly higher anti-staphylo-
coccal IgG levels than the controls
(Supplementary Figure S1 online). To
determine specific responses, the levels
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Figure 1. S. aureus multiple-locus variable number of tandem repeats analysis (MLVA) types identified in
epidermolysis bullosa (EB) patients over a period of B2 years. (a) Summary of the number of different
MLVA types identified in three rounds of sampling. (b) Changes in the S. aureus MLVA types isolated from
35 EB patients in three rounds of sampling. The MLVA typing results were analyzed for individual EB
patients with chronic wounds (n¼ 12) or without chronic wounds (n¼ 23). Black bars, percentage of
patients not carrying S. aureus; white bars, percentage of patients colonized by the same MLVA type in all
three sampling rounds; dark gray bars, percentage of patients colonized by different types in all three
sampling rounds; light gray bars, percentage of patients with alternating MLVA types. URT, upper
respiratory tract.
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of serum IgGs from 13 EB patients
against 43 purified S. aureus antigens
were measured using Luminex technol-
ogy (Figure 2). As controls, the sera from
14 age-matched healthy individuals
were used. For most antigens, the med-
ian fluorescence intensities (MFI) were
higher in EB patients than in the control
group. In particular, the MFI levels for
IgGs against the surface proteins IsdA
(iron-responsive surface determinant A)
and SasG (S. aureus surface protein G),
the secreted proteins IsaA (immuno-
dominant antigen A), SCIN (staphylo-
coccal complement inhibitor), Nuc
(endonuclease), and LytM (peptidogly-
can hydrolase), and the SAgs SEM, SEN,
and SEO were statistically significantly
higher in EB patients. The increased IgG
levels against IsaA, SCIN, Nuc, and
LytM could be explained by the fact
that these proteins are expressed by
many S. aureus types (Ziebandt et al.,
2010). In addition, the egc gene cluster–
encoded SAgs SEM, SEN, and SEO are
among the most prevalent SAgs of S.
aureus (52–66%) (Holtfreter et al.,
2007). Intriguingly, persistent carriers,
bacteremia patients, and furunculosis
patients were found to develop no, or
only low levels of, antibodies against
these SAgs (Grumann et al., 2011;
Holtfreter et al., 2011; Burian et al.,
2012). This suggests that EB patients
are more significantly challenged by
egc SAgs than healthy carriers and
bacteremia or furunculosis patients.
To determine whether carriage of
multiple S. aureus strains has an impact
on anti-staphylococcal IgG levels, we
compared patients colonized by one
MLVA type (n¼ 7) with patients colo-
nized by multiple MLVA types (n¼ 5).
Interestingly, the highest MFI levels
were observed for IgG’s from patients
carrying multiple MLVA types. This
was particularly evident for IgGs
against IsdA, LukD (leukocidin D), HlgB
(gamma-hemolysin B), LytM, LukS,
LukF, and ETA (exfoliative toxin A)
(Figure 2b). Notably, the incidence of
LukS/F is very low, and thus, conceiva-
bly, the respective Luminex signals
represent cross-reactive IgGs against
the more common HlgA/B or LukE/D
proteins (Gravet et al., 1998). A signi-
ficant correlation between anti-staphylo-
coccal IgG levels in serum, wound fluid,
and sterile blister fluid was revealed
in samples from one EB patient
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Figure 2. IgG responses of epidermolysis bullosa (EB) patients to staphylococcal antigens. (a) IgG levels against 43 purified S. aureus antigens in sera of EB
patients (red diamonds; n¼ 13) or age-matched healthy controls (blue triangles; n¼14) were determined by Luminex assays. Median fluorescence intensity (MFI)
values as indicated by color-coded bars (EB patients, red; healthy controls, blue) reflect the levels of antigen-specific IgGs. (b) IgG levels against 43 S. aureus
antigens in sera of EB patients colonized by multiple multiple-locus variable number of tandem repeats analysis (MLVA) types (red triangles; n¼5), or EB
patients colonized by only one MLVA type (green diamonds; n¼7) were determined by Luminex assays. The respective MFI values are indicated by red and
green bars.
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(Supplementary Figure S2 online). Here,
the largest difference concerned 4-fold
lowered anti-IsaA levels in wound fluid.
This implies that future studies on anti-
staphylococcal immune responses in EB
patients can be based on noninvasively
sampled wound fluid.
In conclusion, EB patients are highly
challenged with very diverse S. aureus
types, and carriage of multiple S. aureus
types seems to elicit the highest humoral
responses in these patients. However, we
cannot exclude the alternative possibility
of increased humoral and reduced cell-
mediated immunity in EB patients, which
might have an impact on S. aureus carri-
age. Notably, EB patients do not fre-
quently suffer from S. aureus bacteremia,
and none of the patients who donated
blood was treated for staphylococcal
bacteremia in the 5 years before blood
donation. This suggests that their high
anti-staphylococcal antibody titers may
be protective against invasive S. aureus
infections, which would be consistent
with the protective effects of IsaA-specific
antibodies in mice (Lorenz et al., 2011).
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank the anonymous patients with EB from the
Dutch Epidermolysis Bullosa Registry and health-
care workers from the Department of Dermatology
at the UMCG for their participation in the present
study, as well as the technicians of the Department
of Medical Microbiology at the UMCG for excel-
lent technical support.
Magdalena M. van der Kooi-Pol1,
Corne´ P. de Vogel2,
Gerlinde N. Westerhout-Pluister3,
Yanka K. Veenstra-Kyuchukova1,
Jose´ C. Duipmans4, Corinna Glasner1,
Girbe Buist1, Goffe S. Elsinga5,
Hans Westra5, Hendrik P. J. Bonarius5,
Herman Groen5, Willem J. B. van
Wamel2, Hajo Grundmann1,3,
Marcel F. Jonkman4 and
Jan Maarten van Dijl1
1Department of Medical Microbiology,
University of Groningen, University Medical
Center Groningen, Groningen, The
Netherlands; 2Department of Medical
Microbiology and Infectious Diseases, Erasmus
Medical Center, Rotterdam, The Netherlands;
3Laboratory for Infectious Diseases and
Perinatal Screening, National Institute for Public
Health and the Environment, Bilthoven,
The Netherlands; 4Department of Dermatology,
University of Groningen and University Medical
Center Groningen, Groningen, The Netherlands
and 5IQ Therapeutics, Rozenburglaan 13a,
Groningen, The Netherlands
E-mail: J.M.van.Dijl01@umcg.nl
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online
version of the paper at http://www.nature.com/jid
REFERENCES
Brandling-Bennett HA, Morel KD (2010) Common
wound colonizers in patients with epidermo-
lysis bullosa. Pediatr Dermatol 27:25–8
Burian M, Grumann D, Holtfreter S et al. (2012)
Expression of staphylococcal superantigens
during nasal colonization is not sufficient to
induce a systemic neutralizing antibody
response in humans. Eur J Clin Microbiol
Infect Dis 31:251–6
Graber CJ, Shane AL, Weintrub P et al. (2011)
Clonality of Staphylococcus aureus coloniza-
tion over time in attendees of a camp for
children with chronic dermatoses. Pediatr
Dermatol 28:519–23
Gravet A, Colin DA, Keller D et al. (1998) Charac-
terization of a novel structural member,
LukE-LukD, of the bi-component staphylococ-
cal leucotoxins family. FEBS Lett 436:202–8
Grumann D, Ruotsalainen E, Kolata J et al. (2011)
Characterization of infecting strains and
superantigen-neutralizing antibodies in Sta-
phylococcus aureus bacteremia. Clin Vaccine
Immunol 18:487–93
Holtfreter S, Grumann D, Schmudde M et al.
(2007) Clonal distribution of superantigen
genes in clinical Staphylococcus aureus iso-
lates. J Clin Microbiol 45:2669–80
Holtfreter S, Jursa-Kulesza J, Masiuk H et al. (2011)
Antibody responses in furunculosis patients
vaccinated with autologous formalin-killed
Staphylococcus aureus. Eur J Clin Microbiol
Infect Dis 30:707–17
Kolata J, Bode LG, Holtfreter S et al. (2011)
Distinctive patterns in the human antibody
response to Staphylococcus aureus bactere-
mia in carriers and non-carriers. Proteomics
11:3914–27
Lorenz U, Lorenz B, Schmitter T et al. (2011) Func-
tional antibodies targeting IsaA of Staphylo-
coccus aureus augment host immune
response and open new perspectives for anti-
bacterial therapy. Antimicrob Agents Chemo-
ther 55:165–73
Pope E, Lara-Corrales I, Mellerio J et al. (2012) A
consensus approach to wound care in epider-
molysis bullosa. J Am Acad Dermatol; e-pub
ahead of print 1 March 2012
van der Kooi-Pol MM, Veenstra-Kyuchukova YK,
Duipmans JC et al. (2012) High genetic
diversity of Staphylococcus aureus strains
colonizing patients with epidermolysis bul-
losa. Exp Dermatol 21:463–6
Verkaik NJ, Boelens HA, de Vogel CP et al. (2010)
Heterogeneity of the humoral immune
response following Staphylococcus aureus
bacteremia. Eur J Clin Microbiol Infect Dis
29:509–18
Wertheim HF, Melles DC, Vos MC et al. (2005)
The role of nasal carriage in Staphylococcus
aureus infections. Lancet Infect Dis 5:
751–62
Wertheim HF, Vos MC, Ott A et al. (2004) Risk and
outcome of nosocomial Staphylococcus aur-
eus bacteraemia in nasal carriers versus non-
carriers. Lancet 364:703–5
Ziebandt AK, Kusch H, Degner M et al. (2010)
Proteomics uncovers extreme heterogeneity in
the Staphylococcus aureus exoproteome due
to genomic plasticity and variant gene regula-
tion. Proteomics 10:1634–44
Keratin Intracellular Concentration Revisited: Implications
for Keratin Function in Surface Epithelia
Journal of Investigative Dermatology (2013) 133, 850–853; doi:10.1038/jid.2012.397; published online 29 November 2012
TO THE EDITOR
In 1978, Sun and Green carried out a
densitometry-based analysis of PAGE
samples and reported that keratin
proteins account for 25–35% of total
cellular proteins in human epidermal
keratinocytes serially passaged in pri-
mary culture. This represents an
astounding figure with very significant
implications for the structural support
role of keratin intermediate filaments in
epidermis, and its regulation by post-
translational modifications and/or inter-
action with associated proteins. We
report here on an effort to investigate
X Feng et al.
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